Filing Details
- Accession Number:
- 0001192482-18-000165
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-23 17:05:30
- Reporting Period:
- 2018-04-19
- Accepted Time:
- 2018-04-23 17:05:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1267565 | Collegium Pharmaceutical Inc | COLL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1448914 | Thomas Michael Heffernan | C/O Collegium Pharmaceutical, Inc. 780 Dedham Street, Suite 800 Canton MA 02021 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-04-19 | 44,300 | $26.00 | 545,893 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-19 | 100 | $26.01 | 545,793 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended.
Billionaire Hedge Funds
